Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation conflicts with his earlier answers

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation conflicts with his earlier answers
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/5852b15d609bfef77f0d2c3602e8df07afb918ed"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more"></iframe>

STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

More from Health

STAT+: How Trump’s funding cuts are reshaping the health system

STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026

STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM

STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

More from Health

STAT+: How Trump&#8217;s funding cuts are reshaping the health system

STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026

STAT+: FDA promises new AI guidance, and what happened at Epic&#8217;s UGM

STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

STAT+: How Trump’s funding cuts are reshaping the health system

STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM